• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Xenon Pharmaceuticals Inc. - Common Shares (NQ:XENE)

    52.91 -0.29 (-0.55%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,927,662
    Open 54.09
    Bid (Size) 50.00 (100)
    Ask (Size) 54.62 (100)
    Prev. Close 53.20
    Today's Range 52.53 - 54.73
    52wk Range 30.00 - 63.95
    Shares Outstanding 63,562,303
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing ↗
    Xenon Pharmaceuticals develops therapies for neurological disorders, with a pipeline targeting epilepsy and related conditions. 
    Via The Motley Fool

    Performance

    YTD
    +18.9%
    +18.9%
    1 Month
    -2.1%
    -2.1%
    3 Month
    -4.1%
    -4.1%
    6 Month
    +22.4%
    +22.4%
    1 Year
    +65.9%
    +65.9%

    More News

    Read More
    News headline image
    Xenon Pharmaceuticals Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    Xenon Pharmaceuticals (NASDAQ:XENE) Reports Mixed Q1 Results as Azetukalner Nears FDA Submission ↗
    Via Chartmill
    XENON PHARMACEUTICALS INC (NASDAQ:XENE) Breakout Setup Combines 9/10 Technical Strength with 9/10 Consolidation Quality ↗
    Via Chartmill
    News headline image
    Xenon (XENE) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Xenon Reports Q1 2026 Financial Results and Provides Business Update
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    Xenon to Report Q1 2026 Financial Results on May 7, 2026
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    Xenon to Present at Upcoming Investor Conferences
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    Xenon Pharma Stock Up 55% as Insider Sells $78K in Shares. Here's What Investors Should Know ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Fund Has a $200 Million Bet on a Biotech Stock Up 30% in Days After Phase 3 Breakthrough ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Battery Storage Stock Up 50% in a Year Draws New $110M Investment. Here's What You Should Know ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Biotech Stock Up 685% Draws $80.5 Million Investment Amid Dual FDA Filings ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    The Azetukalner Breakthrough: A Deep Dive into Xenon Pharmaceuticals (XENE)
    Via Finterra
    Topics ETFs Intellectual Property
    News headline image
    Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    The Potassium Channel Breakthrough: A Deep-Dive on Xenon Pharmaceuticals (XENE)
    Via Finterra
    Topics Economy Initial Public Offering Intellectual Property
    News headline image
    XENE Stock Rallies 50% On Epilepsy Trial Data, But One Analyst Thinks Rival Biohaven Still Has ‘Room To Differentiate’ ↗
    Via Stocktwits
    News headline image
    Xenon Pharmaceuticals Announces Proposed Public Offering
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    Top stock movements in today's session. ↗
    Via Chartmill
    Monday's session: top gainers and losers ↗
    Via Chartmill
    Gapping stocks in Monday's session ↗
    Via Chartmill

    Frequently Asked Questions

    Is Xenon Pharmaceuticals Inc. - Common Shares publicly traded?
    Yes, Xenon Pharmaceuticals Inc. - Common Shares is publicly traded.
    What exchange does Xenon Pharmaceuticals Inc. - Common Shares trade on?
    Xenon Pharmaceuticals Inc. - Common Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Xenon Pharmaceuticals Inc. - Common Shares?
    The ticker symbol for Xenon Pharmaceuticals Inc. - Common Shares is XENE on the Nasdaq Stock Market
    What is the current price of Xenon Pharmaceuticals Inc. - Common Shares?
    The current price of Xenon Pharmaceuticals Inc. - Common Shares is 52.91
    When was Xenon Pharmaceuticals Inc. - Common Shares last traded?
    The last trade of Xenon Pharmaceuticals Inc. - Common Shares was at 06/18/26 04:00 PM ET
    What is the market capitalization of Xenon Pharmaceuticals Inc. - Common Shares?
    The market capitalization of Xenon Pharmaceuticals Inc. - Common Shares is 3.36B
    How many shares of Xenon Pharmaceuticals Inc. - Common Shares are outstanding?
    Xenon Pharmaceuticals Inc. - Common Shares has 3B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.